Provoked seizures are not considered to be epilepsy, which is defined as two or more unprovoked seizures, and provoked seizures typically do not require long-term treatment with antiseizure medication ...
Neonatal seizures and hypoxic-ischaemic encephalopathy (HIE) represent critical neurological conditions with profound implications for early brain development and long-term neurodevelopmental outcomes ...
Children with neonatal seizures had a 20.4% cumulative risk for epilepsy by age 22, whereas those without seizures had a risk of 1.15%, a new cohort study found. The risk persisted throughout ...
Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units. A study published in Developmental Medicine & Child Neurology indicates ...
Researchers in Norway conducted a nationwide population-based study to determine the incidence and underlying causes associated with neonatal seizures in infants born at or beyond 36 weeks of ...
Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures SUNNYVALE, ...
Two neonates born to COVID-positive mothers in 2020 displayed early-onset seizures, acquired microcephaly, and had significant developmental delay, a case report showed. In both infants, the ...
(RTTNews) - CeriBell, Inc. (CBLL) announces that the U.S. FDA has granted 510(k) clearance for its next-generation Clarity algorithm to detect electrographic seizures in preterm neonates through ...
Objective: The aim was to study the epidemiological aspects of febrile seizures and to identify etiologies in children from 1 ...
The International League Against Epilepsy (ILAE) has updated the operational classification of epileptic seizures, building upon the framework published in 2017 to establish a common language for all ...
SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious ...